跳至主要内容

Medicilon was awarded the "Industry Outstanding Member Unit Management Award" by the China Laboratory Primate Breeding and Development Association

 Recently, the China Laboratory Primate Breeding and Development Association Industry Academic Exchange Conference and 30th Anniversary Celebration were held as scheduled at the Dragon Lake Princess Hotel in Huadu, Guangzhou.  As a member, Shanghai Medicilon Inc. was invited to attend the conference and was awarded the "Industry Outstanding Member Unit Management Award".

Nonhuman primate research is an indispensable part of preclinical research and plays a link between basic research and clinical trial.  As a one-stop biopharmaceutical preclinical R&D service platform in China, Medicilon established a "non-human primate professional technical service platform" as early as 2008.  After nearly 16 years of experience and technology accumulation, the non-human primate professional technical service platform has established mature models in the fields of ophthalmic diseasesinflammatory and autoimmune diseasesendocrine, metabolic diseases and more.  Medicilon can provide pharmacodynamicspharmacokinetics and safety evaluation tests in compliance with international and China GLP specifications, international AAALAC requirements, FDA standards and ICH requirements, providing strong support for promoting clinical development.

Industry Outstanding Member Unit Management Award.webp

It is worth mentioning that Medicilon's "Professional Technical Service Platform for Non-Human Primates" has been selected into the Shanghai International Services Trade Demonstration Project.  At present, Medicilon has complete animal models such as mice, rats, rabbits, pigs, dogs, and monkeys, which can meet clients' different types of new drug research and development needs.  Among them, the non-human primate experimental facility is the largest laboratory in Shanghai with the largest number of monkeys.

Medicilon respects the life of experimental animals, pays attention to the welfare ethics of experimental animals, and actively implements the "3Rs" principles of use of experimental animals and the "Five Basic Welfare", providing different toys, sports facilities, nutritious fruits, play light music and cartoons for different species of experimental animals to ensure that the animals are in a comfortable, healthy, happy and natural living state.

In the future, Medicilon will maintain and protect the welfare of experimental animals, cherish every experimental opportunity, provide high-quality and efficient scientific research services for global new drug research and development, and empower the innovative development of life sciences.

PS: We would like to express our highest respect to all experimental animals that devote themselves to life sciences!

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Enzyme Activity Assay Service

  Enzymatic assay Lance Assay Alphascreen Assay Z’-LYTE Assay Adapta Assay Kinase-Glo Assay ADP-Glo Assay Ligand Binding Assay ELISA Assay HTRF Assay Enzyme activity assays  are laboratory methods for measuring enzymatic activity. They are vital for the study of enzyme kinetics and enzyme inhibition. Enzyme units : Amounts of enzymes can either be expressed as molar amounts, as with any other chemical, or measured in terms of activity, in enzyme units. Medicilon provides various  enzyme activity assays  for  kinases , phosphatases, proteinases, deacetylase, peptidase, esterase, and other enzymes. Our line of well-characterized immunoassays and biochemical kits ensures accurate and reproducible results. Enzyme is a  large category of bio-molecules  that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high sp